All About Multiple Sclerosis

More MS news articles for March 2003

Multiple sclerosis: new treatments will take on interferons

14 Mar 2001

Several new multiple sclerosis treatments will be launched over the next seven years. Immunosuppressants will be first to hit the market and will take $210 million worth of sales in 2001, growing to $370 million by 2007. Monoclonal antibodies will have the largest market share, estimated to be worth $616 million in 2007 after only two years of launch. These drugs pose a threat to the current dominance of the interferon class.

* Marketed products will have a value of over $3 billion by 2007

* Potassium channel blockers will hit the market in 2006 with sales of $185 million, growing to $243 million the next year

* Other treatments introduced in 2006 will have a combined value of $296 in their initial year and $390 in 2007

© Copyright 2003, DataMonitor